Streetbeat News

Price Targets

SUN

Citigroup analyst Spiro Dounis has upgraded Sunoco (NYSE:SUN) from Neutral to Buy and set a price target of $65.

Portfolio Pulse from Benzinga Newsdesk

June 18, 2024 | 2:39 pm

CEG

UBS analyst Ross Fowler maintains a Buy rating on Constellation Energy (NASDAQ:CEG) and raises the price target from $227 to $249.

Portfolio Pulse from Benzinga Newsdesk

June 18, 2024 | 2:33 pm

TER

UBS analyst Timothy Arcuri maintains a Buy rating on Teradyne (NASDAQ:TER) and raises the price target from $130 to $170.

Portfolio Pulse from Benzinga Newsdesk

June 18, 2024 | 2:31 pm

AVTE

Wells Fargo analyst Tiago Fauth has downgraded Aerovate Therapeutics (NASDAQ:AVTE) from Overweight to Equal-Weight and significantly lowered the price target from $35 to $2.

Portfolio Pulse from Benzinga Newsdesk

June 18, 2024 | 2:28 pm

EQH

UBS analyst Brian Meredith has downgraded Equitable Holdings (NYSE:EQH) from Buy to Neutral while raising the price target from $40 to $43.

Portfolio Pulse from Benzinga Newsdesk

June 18, 2024 | 2:24 pm

KOPN

Lake Street initiates coverage on Kopin (NASDAQ:KOPN) with a Buy rating and sets a price target of $2.5.

Portfolio Pulse from Benzinga Newsdesk

June 18, 2024 | 2:20 pm

PRMW

JP Morgan analyst Andrea Teixeira maintains an Overweight rating on Primo Water (NYSE:PRMW) and raises the price target from $24 to $26.

Portfolio Pulse from Benzinga Newsdesk

June 18, 2024 | 2:16 pm

SKYE

Cantor Fitzgerald analyst Kristen Kluska has reiterated an Overweight rating on Skye Bioscience (NASDAQ:SKYE) and maintained a $14 price target.

Portfolio Pulse from Benzinga Newsdesk

June 18, 2024 | 2:16 pm

NTLA

Cantor Fitzgerald analyst Rick Bienkowski has reiterated an Overweight rating on Intellia Therapeutics (NASDAQ:NTLA) and maintained a $65 price target.

Portfolio Pulse from Benzinga Newsdesk

June 18, 2024 | 2:12 pm